Projects funded by the NCN
AXL receptor signaling in cancer cell growth and drug resistance
2020/39/B/NZ3/03429
Keywords:
cancer cell biology receptor tyrosine kinases AXL receptor GAS6 ligand macropinocytosis nutrient scavenging drug resistance
Descriptors:
- NZ3_1: Cell biology
- NZ3_7: Signal transduction
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ3 - Cellular and developmental biology: cell biology, developmental biology, ageing biology, neurobiology
Host institution :
Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 20 - announced on 2020-09-15
Amount awarded: 2 482 764 PLN
Project start date (Y-m-d): 2021-10-01
Project end date (Y-m-d): 2025-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.